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Abstract.  Laminin and collagen IV are components of 
most basal laminae (BLs). Recently, both have been 
shown to be products of multigene families. The A, 
B1, and B2 subunits of the laminin trimer are products 
of related genes, and the BL components merosin M 
and s-laminin are homologues of the A and B1 
subunits, respectively.  Similarly, five related collagen 
IV chains, al(IV)-ct5(IV), have been described. Here, 
we used a panel of subunit-specific antibodies to de- 
termine the distribution of the laminin and collagen IV 
isoforms in adult BLs. First, we compared synaptic 
and extrasynaptic portions of muscle fiber BL, in light 
of evidence that axonal and muscle membranes inter- 
act selectively with synaptic BL during neuromuscular 
regeneration. S-laminin, laminin A, and collagens 
oL3(IV) and o~4(IV) are greatly concentrated in synap- 
tic BL; laminin B1  is apparently absent from synaptic 
BL; collagens od(IV) and o~2(IV) are less abundant in 
synaptic than extrasynaptic BL; and laminin B2 and 
merosin M  are present at similar levels  synaptically 
and extrasynaptically. These results reveal  widespread 
differences between synaptic and extrasynaptic BL, 
and implicate several  novel polypeptides as candidate 
mediators of neuromuscular interactions. Second, we 
widened our inquiry to assess the composition of sev- 
eral other BLs: endoneurial and perineurial BLs in in- 
tramuscular nerves, BLs associated with intramuscular 
vasculature, and glomerular and tubular BLs in kid- 
ney. Of eight BLs studied, at least seven have distinct 
compositions, and of the nine BL components tested, 
at least seven have distinct distributions. These results 
demonstrate a hitherto undescribed degree of heteroge- 
neity among BLs. 
B 
ASAL laminae (BLs)' throughout the vertebrate body 
are thought to contain a number of common compo- 
nents- notably laminin,  collagen IV, nidogen/entac- 
tin, and a heparan sulfate proteoglycan (reviewed in Timpl 
and Dziadzek,  1986; Martin and Timpl, 1987; Timpl, 1989; 
Inoue,  1989). These molecules are important for maintain- 
ing the structural  integrity of BLs, and for mediating their 
attachment to other components of the extracellular matrix 
and to cell membranes.  In addition,  however, there is evi- 
dence for the existence of molecular differences among BLs, 
at least  some of which are  presumably  related  to tissue- 
specific roles that BLs play. While initial molecular analyses 
of BLs quite naturally focussed on their major and common 
constituents, recent studies have increasingly sought less abun- 
dant, tissue-specific components. 
We have been interested in regional specializations of the 
BL that ensheathes  skeletal  muscle  fibers. Approximately 
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1. Abbreviation  used in this paper:  BL, basal lamina. 
0.1% of this BL lines the synaptic cleft that separates nerve 
from muscle at the neuromuscular junction; the remaining 
99.9% is extrasynaptic and separates the muscle fiber mem- 
brane from endomysial connective tissue space. When motor 
axons regenerate to denervated muscles after nerve injury, 
they preferentially reinnervate the original synaptic sites, and 
differentiate there into nerve terminals. We found that axons 
also preferentially form contacts and differentiate at synaptic 
sites on BL sheaths from which muscle fibers have been re- 
moved,  implicating  components  of BL in the  remarkable 
topographic specificity of reinnervation (Sanes et al., 1978; 
Glicksman and Sanes, 1983). Conceptually similar experi- 
ments, in which myotubes regenerated within BL sheaths in 
the absence of  nerves, demonstrated that synaptic sites on BL 
sheaths  can  influence  the  differentiation  of postsynaptic 
structures  as  well  (Burden  et  al.,  1979; McMahan  and 
Slater, 1984). Together, these experiments suggested the ex- 
istence of synapse-specific components in muscle fiber BL 
that axons and myotubes recognize and to which they re- 
spond (reviewed in Sanes,  1989). 
Immunohistochemical methods have demonstrated molec- 
ular correlates of these functional specializations. Whereas 
antibodies to several components of BL (laminin, collagen 
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synaptic and extrasynaptic  BL (Sanes, 1982; Sanes and Chiu, 
1983; Eldridge et al., 1986), other antibodies stain synaptic 
BL selectively (Sanes and Hall, 1979; Sanes and Chiu, 1983; 
Anderson and Fambrough,  1983;  FaUon et al.,  1985), and 
still others stain extrasynaptic BL more intensely than synap- 
tic BL (Sanes,  1982; Sanes and Chiu, 1983). Recently, mo- 
lecular cloning has revealed that one "synaptic antigen; which 
we call synaptic laminin or s-laminin, is a homologue of the 
B1 subunit of laminin (Hunter et al.,  1989a). Laminin itself 
(a trimer of A, B1, and B2 subunits, all of which are homolo- 
gous to each other) is known to be adhesive for neurons of 
many types, and to be a potent promoter of neurite outgrowth 
(reviewed in Sanes, 1989). We found that a recombinant frag- 
ment of s-laminin is selectively  adhesive for motoneurons 
(Hunter et al.,  1989b) and inhibits neurite outgrowth (Weis 
J., D. Hunter, and J. Sanes, unpublished data). More recently, 
the M subunit of merosin, a molecule present in muscle fiber 
BL but absent from many other BLs  (Lievo and Engvall, 
1988), has been found to be a homologue of the laminin A 
subunit  (Ehrig  et  al.,  1990).  Neurons  also  interact  with 
merosin (Engvall E., and M. Manthorpe, unpublished data). 
Thus, an intriguing possibility is that muscles use a variety 
of laminin-like molecules with different bioactivities to regu- 
late axonal behavior in complex ways. 
The finding that muscles contain several isoforms of lami- 
nin has motivated the two new sets  of histological studies 
reported here. First, we examined the distribution of s-lam- 
inin, merosin M, and the laminin subunits (A, B1, and B2) 
in muscle and in a set of nonmuscle BLs.  Specifically,  we 
asked which subunits are enriched in or excluded from syn- 
aptic BL, and whether subunits occur in specific combina- 
tions that might suggest their mode of association. Second, 
we studied the distribution of another major component of 
BLs, collagen IV, in muscle. Here, we took advantage of re- 
cent studies on the targets of autoimmune attack in human 
Goodpasture syndrome; this work has culminated in the dis- 
covery of novel collagen IV-like chains called c~3(IV), oe4(IV), 
and c~5(IV) to distinguish them from the previously charac- 
terized collagen chains al(IV) and a2(IV) (Butkowski et al., 
1985,  1987; Wieslander et al.,  1984; Hostikka et al.,  1990; 
reviewed in Hudson et al.,  1989).  Collagens composed of 
cd(IV) and c~2(IV) chains, like laminin, are present in most 
BLs, while a3(IV) and a4(IV), like s-laminin and merosin, 
are concentrated in a limited subset of BLs  (Pusey et al., 
1987; Kleppel et al.,  1989a,b;  Butkowski  et al.,  1989).  It 
was therefore natural to ask whether any of the chains of col- 
lagen IV are concentrated in or excluded from synaptic BL. 
Together, our results provide evidence for differences between 
synaptic and extrasynaptic BL, and among BLs in general, 
so numerous that we propose to revise the view that all BLs 
contain an identical set of major structural components. 
Materials and Methods 
Antibodies 
The antibodies used in this study are listed in Table I. The locations of epi- 
topes recognized by antibodies to laminin subunits and homologues are 
shown in Fig.  1. Immunoblotting analyses of antibodies that recognize rat 
antigens, performed as described in Hunter et al.  (1989a),  are illustrated 
in Fig. 2. 
Table L Antibodies Used in this Study 
Antibody  Antibody  Immunogen 
Antigen  designation  type  source 
S-Laminin  C1  Mouse mAb  Rat 
C4  Mouse mAb  Cow 
D5  Mouse mAb  Cow 
D7  Mouse mAb  Cow 
G1  Mouse mAb  Recombinant 
GP1  Guinea pig serum  Recombinant 
R49  Rabbit  serum  Recombinant 
Laminin A  4C7  Mouse mAb  Human 
11D5  Mouse mAb  Human 
Laminin B1  3E5  Mouse mAb  Human 
4El0  Mouse mAb  Human 
Laminin B2  2E8  Mouse mAb  Human 
D 18  Mouse mAb  Rat 
Merosin M  2DI0  Mouse mAb  Human 
2G9  Mouse mAb  Human 
5H2  Mouse mAb  Human 
Collagen cd(IV)  6  Mouse mAb  Cow 
102  Rat mAb  Human 
Collagen ~2(IV)  M24-1  Sheep serum  Human 
Collagen cd,2(IV)  M3F7  Mouse mAb  Human 
Collagen a3(IV)  975  Sheep serum  Human 
17  Mouse mAb  Cow 
Collagen a4(IV)  977  Sheep serum  Human 
85  Mouse mAb  Human 
Laminin.  Laminin purified from the murine Engelbreth-Holm-Swarm 
(EHS) tumor was purchased from Miles Laboratories Inc. (Elkhart, IN) and 
an antiserum was prepared to it in a  rabbit.  A  second rabbit anti-mouse 
EHS laminin antiserum was purchased from Polysciences, Inc. (Warring- 
ton, PA).  Both antisera recognized the A and B subunits of rat tumor-de- 
rived  laminin (Telios,  La  Jolla,  CA)  on  immunoblots. The  B1  and  B2 
subunits are not well resolved on these blots, but the breadth of the band 
indicated that the sera recognize both subunits. These sera also stained lami- 
nin B1 and/or B2 but not s-laminin in extracts of rat kidney basement mem- 
brane (Fig. 2). Previous publications describe the production and character- 
ization of mAbs 4C7 and llD5 to laminin A; 3E5 and 4El0 to laminin B1; 
and 2E8 to laminin B2 (Dillner et al., 1988; Engvall et al., 1986; Gehlsen 
et al., 1989; Engvall et al., 1990). A second mAb to laminin B2, D18, arose 
from a fusion designed to produce mAbs to s-laminin (see below); both DI 8 
and 2E8 recognized laminin B2 but not s-laminin on immunoblots (Fig. 2). 
S-Laminin. mAbs C1, C4, D5, and 137 to s-laminin, have been described 
previously (Sanes and Chiu,  1983; Hunter et al.,  1989a). All four mAbs 
are of the lgG1 class, and all four recognize recombinant s-laminin (Hunter 
et al., 1989a; Green, T., D. D. Hunter, and J. R. Sanes, unpublished data). 
When large amounts of laminin were loaded onto gels, and the resulting im- 
munoblots overdeveloped, C4, but not D5 or D7, cross-reacted faintly with 
the laminin B1 subunit; this cross-reaction was not detectable on immuno- 
blots of kidney extract, presumably because of the relative paucity of lami- 
nin in these samples. In addition to these mAbs, which were raised to BL 
extracts, we prepared several antibodies to s-laminin fragments produced 
in bacteria. The pET RK36 fusion protein, comprising the COOH-terminal 
20 kD of s-laminin was purified as described by Hunter et al. (1989b), and 
used to immunize a rabbit (R49) and a guinea pig (GP1). Both antisera rec- 
ognized authentic s-laminin but not laminin on immunoblots (Fig. 2). A fu- 
sion protein comprising the NH2-terminal 30%  of s-laminin, encoded by 
the cDNA RM12 (Hunter et al., 1989a), was prepared in a similar fashion, 
and used to immunize mice, resulting in the production of mAb G1, which 
also recognized authentic s-laminin but not laminin on immunoblots. By 
using overlapping fusion proteins, we have mapped the epitope recognized 
by G1 to the NHz-terminal 15%  of s-laminin (T.  Green and J. R. Sanes, 
unpublished data). 
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Figure  1.  Location of epitopes recognized by antibodies to laminin subunits and homologues, Domain structures of the polypeptides are 
from Sasaki et al.  (1987,  1988),  Hunter et al.  (1989a),  and Ehrig et al.  (1990).  Dashed line denotes region of merosin M  that has not 
been sequenced.  Characterization of the antibodies is described in Materials  and Methods.  Antibodies whose  epitopes have not been 
mapped are shown beneath the appropriate subunit. 
Merosin.  Three mAbs to human merosin M, 2G9, 2D10, and 5H2 were 
produced in mice. All three antibodies are IgGs, and all react with a COOH- 
terminal fragment of merosin M (Leivo and Engvall,  1988;  Leivo et al., 
1989). 
Collagens IV. Antisera to the NC1 fragments of human collagen chains 
c~2(IV) (serum No.  M24-1), a3(IV) (serum No. 975), and c~4(IV) (serum 
No. 977), were raised in sheep as described by Butkowski et al. (1989) and 
at~nity purified on nitrocellulose-bound antigen (Robinson  et al.,  1988). 
The following mAbs to NC1  fragments of collagen  IV chains were also 
used: mAb 6, mouse anti-bovine ~I(IV); mAb 102, rat anti-human ~I(IV); 
mAb  17,  mouse  anti-bovine a3(IV);  and  mAb  85,  mouse anti-human 
ot4(IV) (Kleppel  et al.,  1989a;  Saus et al.,  1988).  Finally,  we used mAb 
M3F7 (ICN Immunochernicals,  Lisle, IL), which binds to the triple helical 
domain of collagen  cd and c~2 chains (Foellmer et al.,  1983). 
Second Antibodies.  Fluorescein-conjugated  goat antibodies to mouse, 
Figure 2.  Immunoblot analysis of 
antibodies that recognize rat lam- 
inin or s-laminin. Purified rat lam- 
inin (left) or a BL-rich extract of 
adult rat kidney (right; see Hunter 
et  al.,  1989a)  was  submitted to 
gel electrophoresis under reduc- 
ing conditions, and blotted as de- 
scribed in Hunter et al.  (1989a, 
b).  The antibodies used,  and the 
subunits they recognize, are enu- 
merated in Materials and Methods. 
The position of a 200-kD standard 
(myosin)  is  indicated  by  arrow- 
heads. 
Sanes et al. Laminin and Collagens IV  1687 Table II. Staining of  Basal Laminae by Antibodies  to Laminin Subunits and Homologues 
Staining 
Muscle fibers  Nerve trunks  Blood vessels  Kidney 
Chain  Antibody  Species  Synaptic  Extrasynaptic  Perineurial  Endoneurial  Arterial  Capillary  Glomerular  Tubular 
S-laminin  C 1  Rat  +  -  +  -  +  -  +  - 
Human  +  -  +  -  +  -  +  - 
C4  Rat  +  -  +  -  +  -  +  - 
Rabbit  +  -  +  -  +  -  +  - 
Guinea Pig  +  -  +  -  +  -  +  - 
Human  +  -t-  +  -  +  -  +  - 
D5  Rat  +  +  +  +  +  -  +  - 
Rabbit  +  +  +  +  +  -  +  - 
Guinea Pig  +  +  +  +  +  -  +  - 
D7  Rat  +  -  +  -  +  +  +  - 
Rabbit  +  -  +  -  +  +  +  - 
Guinea Pig  +  -  +  -  +  +  +  - 
Laminin A  4C7  Rabbit  +  -  +  -  +  ?  +  + 
Guinea Pig  +  -  +  -  +  ?  +  + 
Human  +  -  +  -  +  ~  +  + 
11 D5  Human  +  -  +  -  +  ?  +  + 
Laminin B1  4El0  Rabbit  -  +  -  +  -  ?  -  + 
Human  -  +  -  +  -  ?  -  + 
3E5  Human  -  +  -  +  -  ?  -  + 
Laminin B2  2E8  Rat  +  +  +  +  +  +  +  + 
Guinea Pig  +  +  +  +  +  +  +  + 
Human  +  +  +  +  +  +  +  + 
D18  Rat  +  +  +  +  +  +  +  + 
Guinea Pig  +  +  +  +  +  +  +  + 
Human  +  +  +  +  +  +  +  + 
Merosin  M  2G9  Rabbit  +  +  -  +  .... 
Human  +  +  -  +  .... 
2D10  Rabbit  +  +  -  +  .... 
Human  +  +  -  +  .... 
5H2  Rabbit  +  +  -  +  .... 
Human  +  +  -  +  .... 
All antibodies were tested on sections of rat, rabbit, guinea pig, and human kidney and muscle. Species in which staining was observed are listed.  +, clear, consis- 
tent staining.  :~,  dim but unequivocal staining.  -,  negative or equivocal staining.  ? indicates variability among sections. 
rabbit, rat, and sheep IgG were purchased from Boehringer Mannheim Diag- 
nostics, Inc. (Indianapolis, IN) and Sigma Chemical Co. (St. Louis, MO). 
Histology 
Adult female Holtzman rats and Hartley guinea pigs were obtained from 
Sasco, Inc. (Omaha, NE); and New Zealand white rabbits from Boswell's 
Bunny  Farm (Pacific,  MO).  Rat muscles were denervated by cutting the 
phrenic  nerve intrathoracically or the  sciatic nerve in  midthigh, both in 
ether-anesthetized animals. The lower leg muscles of a rabbit were dener- 
vated by cutting the sciatic nerve of a halothane-anesthetized animal in mid- 
thigh. Incisions were closed with surgical staples and tissues were collected 
10 d  after surgery. 
Diagnostic biopsies of human muscles were provided by Kenneth Kaiser 
and  Michael  Brooke,  Department of Neurology,  Washington  University 
Medical Center, St.  Louis, MO.  Studies reported here used sections from 
4-, 16-, 33-, and 71-yr-old males and 2- and 4-yr-old females. These biopsies 
had been obtained for evaluation of muscle weakness, but they revealed no 
histological  or  histochemical  abnormalities  upon  examination  by  Dr. 
Brooke.  No age-related differences among specimens were observed with 
the  antibodies  used.  Pieces of human kidney,  obtained at autopsy,  were 
provided by Dr. Eric Simon, Department of Medicine, Washington Univer- 
sity Medical Center. 
Tissues were sectioned and stained as described in Covault and Sanes 
(1986). Briefly, unfixed specimens were frozen in liquid N2-cooled isopen- 
tane and cross sectioned at 2-6/~m in a cryostat. Sections were incubated 
with antibody ("~1  h),  washed, reincubated with fluorescein-second anti- 
body ("~1 h),  washed again, mounted in glycerol-para-phenylenediamine, 
and observed with epifluorescent illumination. Rhodamine-c~-bungarotoxin 
was mixed with the second antibody, to mark synaptic sites in sections of 
muscle. 
Results 
Laminin Isoforms at the Neuromuscular Junction 
S-Laminin.  We showed previously that mAbs C1, C4, D5, 
and D7, all of which recognize s-laminin, stain synaptic BL 
more intensely than extrasynaptic BL on rat muscle fibers 
(Sanes and Chiu, 1983; Hunter et al., 1989a). We have now 
extended this study in two ways. First, we stained cryostat 
sections of rabbit, guinea pig, and human muscle with the 
anti-s-laminin mAbs.  Synaptic sites were identified by co- 
staining  with  rhodamine-c~-bungarotoxin, which  binds  to 
acetylcholine  receptors  concentrated  in  the  postsynaptic 
membrane (see Sanes and Hall,  1979; Covault and Sanes, 
1986). At least two mAbs cross reacted with each species 
tested.  In each case,  s-laminin-like immunoreactivity was 
The Journal of Cell Biology, Volume 111,  1990  1688 Figure 3.  Staining  of synaptic and extrasynaptic  BL of skeletal  muscle fibers by antibodies  to s-laminin (a-c), laminin A (d-f), laminin 
B1 (g-i), laminin B2 (j-l), and merosin M (m-o). Left panels  show, at low magnification,  that extrasynaptic  BL is stained by antibodies 
to B1, B2, and merosin but not by antibodies  to s-laminin or A. Right panels  show, at higher magnification,  staining  of synaptic  sites, 
identified by counterstaining with rhodamine-c~-bungarotoxin  (b-o are photographed with fluorescein  optics; b'-o' are the same fields pho- 
tographed with rhodamine optics).  S-Laminin and laminin A are concentrated at synaptic  sites,  B1 is absent  from synaptic  sites,  and B2 
and merosin are present both synaptically and extrasynapticaUy.  Asterisk  in d indicates  a laminin  A-positive  blood vessel  (see Fig.  6). 
Antibodies  used and species  stained  are:  (a and b) D7, rabbit;  (c) C1, human;  1 (d and e) 4C7, rabbit;  (f) 4C7, guinea pig; (g and h) 
4El0, rabbit; (i) 3E5, human; (i and k) D18, human; (l) 2E8, human; (m) 2D10, human; (n) 2D10, rabbit;  (o) 2G9, rabbit.  Bars: (m) 50 
#m; (o') 20 #m. Figure 4.  Synaptic sites in rat muscle are  selectively stained by 
monoclonal (a, D5; b, D7) and polyclonal (c, GP-1) antibodies to 
s-laminin. However, mAb D5 also stains extrasynaptic BL faintly. 
a'-c' are  same fields as a-c,  cvunterstained  with rhodamine-a- 
bungarotoxin. Bar, 20 #m. 
concentrated at  synaptic  sites  (Table II  and  Fig.  3,  a-c). 
Thus, the synaptic localization of s-laminin is not peculiar 
to  rat,  but is  apparently  a  general  feature of mammalian 
muscle. 
Second, we tested several new antibodies to s-laminin. Al- 
though our original set of mAbs all stained synaptic BL more 
intensely than extrasynaptic BL, two (C4 and D5) stained ex- 
trasynaptic BL to a limited extent, while the other two (C1 
and D7) did not (Fig. 4, a  and b). Some differences among 
antibodies were also seen in nonmuscle tissues (see below). 
These differences could reflect the presence of cross-reactive 
molecules in  some BLs,  selective exposure or masking of 
some epitopes (e.g., by variable glycosylation), or variations 
in primary structure (e.g., as a consequence of alternative 
splicing).  To address these possibilities, we prepared poly- 
clonal antisera to a COOH-terminal fragment in a rabbit and 
a guinea pig, reasoning that they would recognize a broad ar- 
ray of epitopes. Both antisera recognized s-laminin but not 
laminin on inununoblots (Fig. 2), and both stained synaptic 
sites far more intensely than extrasynaptic areas on cryostat 
sections of muscle (Fig. 4 c). In addition, because the poly- 
clonal antisera and at least three of the four mAbs (the C1- 
binding site has not been localized) recognize epitopes lo- 
cated on the COOH-terminal 40% of the molecule (Fig.  1), 
we  tested  a  mAb,  G1,  that  recognizes an  epitope  on  the 
NH~-terminal  15%  of s-laminin (Fig.  1 and  see Materials 
and Methods).  Like the other antibodies to s-laminin,  G1 
stained synaptic sites intensely and extrasynaptic areas weakly 
if at all (not shown). Together, these immunohistochemical 
results all support our conclusion that s-laminin is concen- 
trated at synaptic sites. 
Laminin. Polyclonal antisera to laminin stain both synap- 
tic and extrasynaptic portions of muscle fiber BL (Sanes, 
I982).  However, these antisera  recognize all  three of the 
subunits contained in  the tumor-derived laminin to which 
they were raised, A, B1, and B2 (Fig. 2). One cannot, there- 
fore, conclude that any individual subunit is present both 
synaptically  and  extrasynaptically.  We  therefore  tested  a 
panel of mAbs that recognize individual subunits.  Because 
direct biochemical identification of the subunits is not feasi- 
ble in situ, we used two mAbs to each subunit and stained 
muscle from several species to enhance our confidence in the 
immunohistochemical results. In fact, staining of all species 
with  both  antibodies  yielded  consistent  results  for  each 
subunit. 
Laminin A is concentrated at synaptic sites and is not de- 
tectable in extrasynaptic areas; staining is precisely coinci- 
dent with  that  of rhodamine-ot-bungarotoxin, and  clearly 
reflects the selective association of this subunit with synaptic 
BL (Fig. 3, d-f and Table 1I). In contrast, laminin B1 is con- 
centrated in extrasynaptic areas and is present at consider- 
ably lower levels, if at all, at synaptic sites (Fig. 3, g-i). The 
close apposition of Bl-positive Schwann cell BL to synaptic 
BL makes it difficult to determine whether or not some syn- 
aptic sites are faintly B1 positive in human and rabbit muscle. 
However, staining by the anti-B1 mAbs used here is strik- 
ingly similar to that previously seen in rat muscle with the 
anti-laminin mAbs C21 and C22. These were shown to stain 
extrasynaptic but not synaptic BL by both light and elec- 
tron microscopic immunohistochemical methods (Sanes and 
Chiu,  1983; Chiu and Sanes,  1984; Gatchalian, C.,  A.  Y. 
Chiu,  and L  R.  Sanes.  1985. J.  Celt Biol.  101[No.  5,  Pt. 
2]:89a[Abstr.]). MAbs C21 and C22 do not react with dena- 
tured laminin on immunoblots, and have therefore not been 
assigned to an individual subunit;  however, in light of the 
present results, we suggest that they recognize a Bl-depen- 
dent epitope. Finally, antibodies to laminin B2 stained both 
synaptic and extrasynaptic BL, although synaptic sites were 
slightly more intensely stained than extrasynaptic areas (Fig. 
3, j-l).  The enhanced staining  of synaptic sites probably 
reflects the presence of struts of  BL that extend into invagina- 
tions of  postsynaptic membrane called junctional folds (e.g., 
Sanes et al., 1978). Because junctional folds are present only 
at synaptic sites there is two to threefold more BL per unit 
circumference in synaptic areas than extrasynaptically (see 
Sanes and Chiu, 1983, for details). Thus, laminin B2 is prob- 
ably present at similar levels in synaptic and extrasynaptic BL. 
Merosin. Three mAbs were available that recognize mero- 
sin M, a novel homologue of laminin A, in human and rabbit 
tissue (Fig.  1 and Table I).  Previous work has established 
that merosin is present in extrasynaptic areas of skeletal mus- 
cle fibers (Lievo and Engvall,  1988), but we did not know 
whether it was also present in synaptic areas. All antibodies 
to merosin M clearly stained both synaptic and extrasynaptic 
areas of both human and rabbit muscle fibers (Table 11 and 
Fig. 3, m-o). In general, synaptic areas were stained some- 
what more intensely than extrasynaptic areas.  However, as 
for laminin B2 (see above), the difference presumably re- 
flects the greater quantity of BL at these sites. In an), event, it 
is clear that merosin M is present throughout muscle fiber BL. 
Laminin lsoforms in Nonmuscle Cells 
Sections  of  skeletal  muscle  generally  contain  structures 
The Journal of Cell Biology, Volume  111, 1990  1690 Figure 5. Distribution of laminin subunits and homologues in intramuscular nerve. (a) Anti-s-laminin stains perineurial BL more intensely 
than endoneurial BL (C4, rabbit). (b) Anti-laminin A stains nerve poorly (4C7, rabbit); outline of nerve indicated by arrowheads. However, 
faint staining of perineurial BL by anti-laminin  A is consistently detectable and can be seen with long photographic exposure (c). (d) 
Anti-laminin B1 stains endoneurial but not perineurial BL (4El0, rabbit).  (e) Anti-laminin B2 stains both endoneurial and perineurial 
BL (2E8, human). (f) Anti-merosin stains endoneurial but not perineurial BL (2G9, rabbit). Bar, 20 t~m. 
other  than  muscle  fibers,  including  intramuscular  nerve 
branches.  Because our work is motivated by an interest in 
molecules that axons  encounter,  we  routinely determined 
whether or not nerve-associated BLs were stained by each 
antibody. In addition, we assessed the staining of intramus- 
cular  blood  vessels,  which  frequently  accompany  nerve 
branches. Finally, because we previously found a more re- 
stricted distribution of s-laminin than of laminin in kidney 
(Sanes and Chiu, 1983; Hunter et al.,  1989a), we tested the 
subunit-specific mAbs on sections of kidney. 
Nerve. In peripheral nerves, each axon is ensheathed by 
myelinating  or  nonmyelinating  Schwann  cells,  and  each 
axon-Schwann cell unit is surrounded by a BL called the en- 
doneurial BL. Fascicles of axon-Schwann cell units are en- 
circled by a multilamellar cellular sheath, called the perineu- 
rium, which also bears BL. Antibodies to s-laminin stained 
perineurial BL far more intensely than endoneurial BL (Fig. 
5 a).  In contrast, antibodies to laminin B1 and to merosin 
M stained endoneurial BL but not perineurial BL (Fig. 5, d 
and f). Antibodies to laminin B2 stained both endoneurial 
and perineurial BL with similar intensity (Fig. 5 e), whereas 
antibodies to laminin A  did not stain either BL intensely 
(Fig. 5 b). At high magnification, however, weak staining of 
perineurial BL by anti-laminin A was detectable (Fig. 5 c). 
While considerably weaker than staining of end-plates or ar- 
terioles  (see below)  in  the  same  sections,  the  staining  of 
perineurium by antibodies to laminin A was consistent and 
specific. 
Blood  Vessels.  The arterial  vessels that  accompany in- 
tramuscular nerves provided further evidence that laminin 
subunits are differentially  distributed. All antibodies to s-lam- 
inin and to laminin A  stained the BL of small arteries and 
arterioles intensely (Fig.  6, a  and b), describing a pattern 
which suggested that smooth muscle BL (see Fawcett, 1986) 
is immunoreactive (Fig. 6 a, inset). These vessels were con- 
sistently the most intensely s-laminin-  and laminin-A-im- 
munoreactive structures in sections of muscle. Antibodies to 
laminin B2 also stained arterial BL (Fig. 6 d). In contrast, 
antibodies to laminin B1  and to merosin M  failed to stain 
arterial vessels in any species tested (Fig.  6,  c  and e  and 
Table II). 
The intramuscular vasculature consists of capillaries and 
venules as well as arterial vessels. Capillary BL was stained 
by both antibodies to laminin B2, but not by any of the anti- 
bodies to merosin M (Fig. 3, j  and m). Interestingly just one 
of the mAbs to s-laminin, D7, stained capillary BL, and anti- 
bodies to laminin A and B1 stained capillary BL in some sec- 
tions but not in others (Table II).  Possible explanations for 
this  variability include the presence of other laminin-like 
subunits with which some mAbs react, real interindividual 
variation in the composition of capillary BL, and the exis- 
tence of multiple subtypes of capillaries. In general, the BL 
of capillaries and of venules exhibited similar patterns of im- 
munoreactivity in any given individual or species. 
Kidney. Early evidence of the site-restricted expression of 
laminin  isoforms was  the  staining  of glomerular but  not 
tubular BL by antibodies now known to recognize s-laminin 
(Sanes and Chiu, 1983). In addition, several mAbs to laminin 
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differentially (Wan et al.,  1984; Leu et al.,  1986; Horikoshi 
et al., 1988; Abrahamson et al., 1989; Gatchalian, C., A.  Y. 
Chiu,  and J.  R.  Sanes.  1985.  J.  Cell Biol.  101[No.  5,  Pt. 
2]:89a[Abstr.]).  In view of these results, and new results on 
collagen isoforms presented below, we compared the distri- 
bution of the laminin subunits to that of s-laminin in kidney. 
In rabbit,  guinea pig,  and human,  as in rat,  antibodies to 
s-laminin  stained  glomerular BL  far more intensely  than 
tubular BL (Fig.  7 a  and Table II). In contrast,  antibodies 
to laminin B1 stained tubular BL but did not react detectably 
with  glomerular BL;  glomerular  mesangium was  weakly 
laminin-Bl-positive in some species (Fig. 7 c). This pattern 
is similar to that seen previously with several mAbs to lami- 
nin (Sanes and Chiu,  1983;  Leu et al.,  1986;  Abrahamson 
et al., 1989), some of which we now believe to recognize B1 
(4El0, C21, and C22; see above). Antibodies to laminin B2 
stained both glomerular and tubular BL (Fig. 7 d), while an- 
tibodies to merosin stained neither (Fig. 7 e). Finally, anti- 
laminin A  stained both glomerular and tubular BL (Fig.  7 
b),  although  the  staining  was fainter than that of synaptic 
sites or blood vessels. In a previous study, only a subset of 
kidney BLs were reported to be stained by an antibody to the 
E3 fragment of laminin A  (Ekblom et al.,  1990);  we have 
no explanation for the discrepancy, but note that low levels 
of laminin A  mRNA have been found in both tubules and 
glomeruli  by  in  situ  hybridization  (Laurie  et  al.,  1989). 
Thus, in kidney as in muscle, different BLs contain different 
combinations of laminin-related proteins. 
Laminin lsoforms in Denervated Nerve and Muscle 
After  nerve  injury,  axons  regenerate  through  denervated 
nerve trunks and into denervated muscles, where they form 
new  neuromuscular junctions.  The axons frequently grow 
along BLs, and evidence obtained both in vivo and in vitro 
indicates that laminin is an important promoter of their ex- 
tension (reviewed in Sanes, 1989). It was therefore of interest 
to test the possibility that denervation affected the distribu- 
tion of one or more laminin-like proteins.  Accordingly, we 
stained sections of 10-d denervated rat and rabbit muscle and 
nerve  with  the  panel  of antibodies  described  above.  Di- 
aphragm and soleus muscles were studied in rat, soleus and 
extensor  digitorum  longus  in  rabbit,  and  intramuscular 
nerve branches  and  sciatic  nerves  in  both  species.  In  all 
cases, similar results were obtained: denervation had no con- 
sistent or major effect on the staining of synaptic, extrasynap- 
tic, endoneurial, or perineurial BL by any antibody (Fig. 8; 
see also Sanes et al.,  1986). Thus, although effects ofdener- 
vation on levels of laminin synthesis might not be detected by 
Figure 6.  Distribution of laminin subunits and homologues in in- 
tramuscular  arterioles.  (a) Anti-s-laminin  (D7, rabbit).  (b) Anti- 
laminin A (4C7, rabbit).  (c) Anti-laminin  B1  (4El0,  rabbit).  (d) 
Anti-laminin B2 (2E8, human).  (e) Anti-merosin  (2G9, rabbit). 
Arteriole BL is s-laminin, laminin A, and laminin B2 positive, but 
laminin B1 and merosin negative. Arrowheads indicate outlines of 
arterioles in c and e; faint staining of vessel in c is autofluorescence 
of  the internal elastic lamina. Muscle fibers are stained in c-e. Inset 
shows loop-like staining, which presumably corresponds to smooth 
muscle BL, and is characteristic of laminin A as welt as s-laminin. 
Bar:  (a-e) 50 #m; (inset) 30 #m. 
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tion of these molecules affect the ability of nerve to promote 
axon outgrowth or of denervated muscle to accept synapses. 
Particularly noteworthy is the lack of effect of denervation on 
the apparent abundance of laminin A: this subunit is thought 
to bear a neurite outgrowth-promoting site (Tashiro et al., 
1989), but is not detectable in endoneurial BL along which 
axons preferentially regenerate (Sanes,  1989). 
Collagen IV Isoforms in Human Muscle 
In human kidney, the collagen ot3(IV), ot4(IV), and ot5(IV) 
chains are concentrated in glomerular BL, as is s-laminin, 
although at least c~3(IV) and c~4(IV), unlike s-laminin, are 
also present in a subset of tubular BLs (Fig. 9 a; Kleppel et 
al., 1989a,b; Butkowski et al., 1989; Hostikka et al., 1990). 
In contrast, the al(IV) and ot2(IV)  chains are present in all 
tubular  and  glomerular BL,  as  is  laminin B2  (Fig.  9  b). 
Struck by these parallels, we examined the distribution of  the 
type IV collagen chains in skeletal muscle. To this end, we 
stained  tissues  with  antibodies  specific  for  the  al(IV), 
a2(IV),  ~3(IV), and a4(IV) chains (Table I); discovery of 
the o~5(IV) chain (Hostikka et al.,  1990) was reported after 
completion of this work.  Preliminary tests showed that the 
antibodies to ~3(IV) and o~4(IV) either did not stain rabbit, 
rat, hamster, guinea pig, or mouse kidney or, in a  few in- 
stances, did stain but did not distinguish glomerular from 
tubular  BL.  We  therefore  limited  this  study  to  human 
muscle. 
Monoclonal antibody  17,  which  is  specific for o~3(IV), 
selectively stained synaptic sites in human muscle (Figs. 9 
d and 10 a). Extrasynaptic BL, as well as arterial, capillary, 
endoneurial, and perineurial BL were not detectably stained 
by this antibody, even after prolonged incubation (Fig. 9, d 
and g). In muscle spindles, motor endplates were mAb 17- 
positive,  whereas  the  extrasynaptic  surfaces  of intrafusal 
fibers and  spindle capsules  (which are s-laminin-positive; 
Sanes and Chiu,  1983) were negative (Fig. 9 h). Similar re- 
suits were obtained with polyclonai anti-a3(IV) (antiserum 
975; Fig.  10 b), although staining by the antiserum was less 
intense than that obtained with mAb  17. Thus, o~3(IV)-like 
immunoreactivity is concentrated at synaptic sites in human 
muscle. 
In several instances, antibodies to the collagen ot3(IV) or 
a4(IV) chains have been found to stain tissue only after sec- 
tions were incubated with urea in acid (e.g., Butkowski et 
al.,  1989; Kleppel et al.,  1989a; Thorner et al.,  1989); this 
treatment denatures the collagen chain to expose an epitope 
that  is  buried  in  the  native molecule (Wieslander  et  al., 
1985). Although mAb 17 and antiserum 975 stained synaptic 
sites and glomerular BL without denaturation, it was possi- 
ble  that  additional  deposits  of ot3(IV)  were  present  ex- 
trasynaptically  but  masked  in  the  sections.  We  therefore 
treated sections of kidney and muscle with 6  M  urea,  100 
mM glycine, pH 3.2 (Kleppel et al.,  1989a) before staining 
Figure 7. Distribution of laminin suhunits and homologues in kid- 
ney BLs. (a) Anti-s-laminin (DS, rabbit). (b) Anti-laminin A (4C7, 
human). (c) Anti-laminin B1 (3E5, human). (d) Anti-laminin B2 
(2E8, human).  (e) Anti-merosin M (2D10, human).  Glomerular 
(G) BL is stained by antibodies to s-laminin, laminin A, and lami- 
nin B2; inset shows glomerular BL stained by mAb C4 at higher 
power. Tubular (T) BL is stained by antibodies to laminin A, B1, 
and B2. Anti-laminin  B1 also stains glomerular mesangium (ar- 
rows in c).  Arrowheads outline glomerulus  in e which appears 
faintly merosin M positive. Bar: (a-e) 50/~m;  (inset) 20 ftm. 
Sanes et al. Laminin and Collagens IV  1693 Figure 8. Distribution of laminin subunits and homologues in denervated rabbit muscle (a-d) and sciatic nerve (e-h).  (a) Anti-s-laminin 
(137). (b and f) Anti-laminin A (4C7). (c and g) Anti-laminin B1 (4El0).  (d) Anti-merosin (2D10). (e) Anti-s-laminin (C4). (h) Anti- 
merosin (2G9). Perineureum is arrowed in e-h. Small blood vessels are visible in a, b, and f. Denervation has no obvious effect on the 
distribution of these antigens; compare with Figs. 3 and 5. Bar: (a-d)  100 #m; (e-h) 50 #m. 
them with mAb  17.  Treated sections were more intensely 
stained than native sections, but the specificity of staining 
was unaffected by denaturation, both in kidney (not shown) 
and in muscle (Fig.  10 c).  In muscle, acid-urea treatment 
abolished reactivity of acetylcholine receptors with rhoda- 
mine-ot-bungarotoxin (Fig.  10 c), but mAb  17-stained syn- 
aptic sites were readily identifiable by their size, shape, and 
arrangement. Furthermore, the enhanced clarity of staining 
after such treatment made it possible to discern fine stria- 
tions corresponding to the short struts of BL that penetrate 
junctional folds in the postsynaptic membrane (Fig. 10 d; see 
Sanes,  1982 and Sanes and Chiu,  1983  for electron micro- 
scopic immunohistochemistry with antibodies to other BL 
antigens). Thus, although ultrastructural localization was in- 
feasible in the present study, there is little doubt that antibod- 
ies to tx3(IV)  stain synaptic BL. 
mAb 85, which recognizes the a4(IV) chain, stained un- 
treated sections of  kidney and muscle poorly. After treatment 
with acid-urea, however, mAb 85 stained glomerular BL and 
a subset of tubular BLs intensely in kidney (not shown) and 
synaptic BL intensely in muscle (Fig.  10 e). Similar results 
were obtained with serum 977,  a polyclonal antiserum to 
collagen u4(IV). In both tissues, the distribution of a4(IV) 
was identical to that of a 3(IV). This result is consistent with 
the suggestion that the a3(IV) and c~4(IV) chains occur to- 
gether within a single triple helical collagen molecule (Hud- 
son et al.,  1989). 
Antibodies to collagen chains cd(IV) (mAbs 6 and  102) 
and c~2(IV) (serum M24-1)  and to the txl, t~2 trimer (mAb 
M3F7) stained both glomerular and tubular BLs in kidney 
(Fig. 9 c) and both synaptic and extrasynaptic BL in muscle 
(Fig.  10 f). Capillary and arterial BLs in muscle were also 
stained by these antibodies (Fig. 9 c), as were endoneurial 
and perineurial BLs in nerves (Fig. 9 e) and intrafusal fiber 
and capsular BLs in muscle spindles (Fig. 9 f). Thus, the 
collagen IV chains t~l(IV) and ct2(IV) appear to be common 
constituents of all BLs. 
On the other hand, the antibodies to t~I(IV) and c~2(IV) did 
reveal subtle differences among BLs. As previously reported 
(Butkowski et al.,  1989; Kleppel et al.,  1989a), regions of 
the glomerular BL that are rich in ot3(IV) and ot4(IV) chains 
are relatively poor in al(IV) and a2(IV) (Fig. 9, a  and b). 
Similarly, synaptic BL, which is et3(IV)- and ct4(IV)-rich, 
was less intensely stained by antibodies to al(IV) and ct2(IV) 
than neighboring stretches of extrasynaptic BL (Fig.  10 f). 
Although this difference was not striking,  it is particularly 
significant in light of the fact that there is two- to threefold 
more BL at synaptic sites than extrasynaptically (see above, 
and Fig. 3, k-o). Furthermore, the difference was seen with 
antibodies  to  the  globular  domains  of both  al(IV)  and 
ot2(IV). In addition, extrasynaptic BL was stained more in- 
tensely than synaptic BL by mAb M3F7, which binds to the 
triple helical region of the txl,c~2 trimer,  distant from the 
globular domain (Fig. 10 a). This result decreases the likeli- 
hood that the dim staining of synaptic sites merely reflects 
local masking of determinants in the globular domain. Thus, 
The Journal of Cell Biology, Volume  111,  1990  1694 Figure 9. Distribution of collagen IV chains in human kidney and muscle. Anti-~l(IV) (mAb 102) stain both glomerular and tubular BLs 
in kidney (a), muscle fiber and vascular BLs in muscle (c), endoneurial and perineurial BLs in nerve (e), and capsular and intrafusal fiber 
BLs in muscle spindles (f).  In contrast,  anti-c~3(IV) (mAb 17) stains glomerular BL and a limited subset of tubules in kidney (b), no 
BLs except synaptic BL in muscle (d), and muscle spindles (h), and no BLs in nerve (g). Identity of arrowed synaptic sites in d and h 
was confirmed by counter staining with rhodamine ~-bungarotoxin.  Sections in d, g, and h are serial to those in c, e, andf respectively. 
Bar in g:  (a-e, and g) 50/~m; bar in h:  (fand h) 20/~m. 
the ~I(IV) and ~2(IV) chains appear to be less abundant in 
synaptic than extrasynaptic BL. 
Discussion 
We have used immunohistochemical methods to map the dis- 
tribution of laminin- and collagen IV-related proteins in the 
BLs of muscle and kidney.  Our results,  which are summa- 
rized in Table III, provide new insights into the composition 
of BLs in general and the molecular architecture of synaptic 
BL in particular. 
Heterogeneity of BLs 
Although BLs have been subjected to biochemical study for 
many years (Kefalides,  1970),  their analysis was long com- 
plicated by the extreme insolubility of adult BLs in aqueous 
solutions and by the extensive covalent cross-linking of their 
components. A major advance, therefore, was the discovery 
of tumor cell lines that secrete large amounts of matrix mate- 
rial in relatively soluble form. Laminin, collagen IV, entac- 
tin/nidogen,  and  BL-associated heparan  sulfate proteogly- 
cans were all discovered and have been characterized most 
extensively  using  such  cells  (Timpl  and  Dziadek,  1986; 
Timpl,  1989).  With  rare  exceptions,  antibodies  to  these 
tumor-derived molecules stained all BLs in fetal and adult 
mammals (Laurie et al.,  1983;  Inoue,  1989).  Accordingly, 
a prevailing view arose that most BLs share many molecular 
features. 
At the same time, it has been generally acknowledged that 
BLs are heterogeneous to  some degree.  Both biochemical 
(Kefalides,  1970)  and  immunohistochemical  (Pierce  and 
Nakane,  1967)  comparisons originally pointed to this con- 
Sanes et al. Laminin and Collagens IV  1695 Figure 10. Presence of collagen IV chains at synaptic sites in human muscle. (a, c, and d) Anti-a3(IV) mAb 17. (b) Anti-u3 (IV) serum 
975.  (e) Anti-c~4(IV) mAb 85. (f) Anti-ul(IV) mAb 6. (g) Anti-~l,2(IV) mAb M3F7. (h) No first antibody. (a'-h') Same fields as a-h, 
counterstained with rhodamine-c~-bungarotoxin. Sections in c-e were treated with acid-urea, which abolishes reactivity with bungarotoxin. 
Struts of BL that enter junctional folds are visible in d. Bar: (d)  10/xm; (a-c, e-h, and a'-h') 20 ~m. 
clusion.  However,  difficulties of solubilizing BLs,  and  of 
isolating any but a  few atypically thick BLs in pure form, 
complicated this interpretation. More recently, mAbs have 
been produced in several laboratories that stain only a subset 
of BLs  in  immunohistochemical  assays  (e.g.,  Sanes  and 
Chiu,  1983;  Fitch and  Linsenmeyer,  1983;  Hessle  et al., 
1984; Wan et al., 1984; Leu et al., 1986; Pusey et al., 1987; 
Horikoshi et al.,  1988;  Kleppel et al.,  1989a).  In many of 
Table IlL Occurrence of  Laminin and Collagen IV Isoforms 
in Various BLs 
Laminins  Collagens IV 
A  B1  B2  mer M  S-Laminin  al  ct2  t~3  ~4 
Muscle  fiber 
Synaptic  +  -  +  +  +  +  +  +  + 
Extrasynaptic  -  +  +  +  -  +  + 
Nerve 
Endoneurial  -  +  +  +  -  +  + 
Perineurial  ±  -  +  -  +  +  + 
Kidney 
Distal tubular  +  +  +  -  -  +  +  +  + 
Proximal tubular  +  +  +  -  -  +  + 
Glomerular  +  -  +  -  +  ±  ±  +  + 
Arterial  +  -  +  -  +  +  + 
these  cases,  however,  it  has  been  difficult  to  determine 
whether an absence of immunoreactivity indicates absence 
of the antigen or merely reflects masking of the epitope in 
question. Indeed, differential access has been proposed as an 
explanation for differential staining in some cases (e.g., Leu 
et al.,  1986;  Horikoshi et al.,  1988).  Nonetheless, at least 
some molecular differences among BLs (e.g., the differences 
between synaptic and extrasynaptic regions of muscle fiber 
BL, which provided the starting point for the present study) 
are well established. 
Our results confirm and extend these observations. Of the 
eight BLs studied in detail, at least seven have distinct com- 
positions,  and  of the  nine  BL components  tested,  at  least 
seven have distinct distributions (see Table In). To some ex- 
tent these conclusions are subject to caveats noted above: ab- 
sence of immunoreactivity might not reflect absence of anti- 
gen, and presence of immunoreactivity could result from the 
presence of a related antigen. However, we obtained consis- 
tent results with at least two antibodies to each protein and 
(for the laminins) in at least two different species. Thus,  it 
is likely that our results accurately reflect the distribution of 
the antigens. Furthermore, because we focussed on isoforms 
of major structural components of BLs, we believe that the 
heterogeneity observed reflects major and important molec- 
ular differences among BLs. 
Thus,  we  now  conclude  that  each  BL  contains  some 
laminin-like and collagen IV-like molecules, but that these 
vary from one BL to another, and are members of mulfigene 
The Journal of Cell Biology, Volume  111,  1990  1696 families. In this regard, BLs are analogous to the sarcomeres 
of muscle fibers. Each fiber contains myosin heavy and light 
chains, actin, tropomyosin, and so on.  However, the early 
belief that each component is unique has been supplanted by 
the realization that each is actually a group of homologous 
proteins encoded by a family of related genes (for example, 
see Emerson et al.,  1986). The contractile properties of in- 
dividual  muscle  fibers  reflect  the  particular  isoforms  of 
which its sarcomeres are composed. Likewise, the laminins 
and collagens IV may play similar roles in all BLs, but the 
unique  properties  of each  BL may  be  determined  by  its 
isotype. 
Laminins and Collagens IV 
Initially, the laminin of authentic BLs was presumed to be 
identical to tumor-derived laminin:  a trimer of A, B1, and 
B2 subunits, all of which are homologous and similar in do- 
main structure (Sasaki et al., 1987, 1988; reviewed in Timpl, 
1989; see Fig.  1). Early evidence for laminin isoforms was 
the apparent absence of the A chain from laminins produced 
by several cell types (Timpl, 1989); however, this observa- 
tion was  controversial because A  chains are known to be 
more protease labile than B chains (Rao et al., 1982). More 
direct evidence for isoforms is  the  purification of variant 
laminins  (Paulsson and Saladin,  1989;  Ehrig et al.,  1990, 
and references therein), and our demonstration that s-lam- 
inin and merosin M  are homologues of laminin B1 and A, 
respectively (Hunter et al.,  1989a;  Ehrig et al.,  1990). 
Given the  existence of variant  laminins  and  novel iso- 
forms, the question of how individual polypeptides are com- 
bined into oligomers becomes an important one. Our results 
suggest some possible rules of assembly. First, each BL we 
studied contains either laminin B1 or s-laminin;  none con- 
tains both. This pattern is consistent with the possibility that 
these polypeptides can substitute for each other in a laminin- 
like trimer. Second, six of the BLs contain only laminin A, 
and two contain only merosin; only synaptic BL contains 
both. As for s-laminin and B1, these observations are consis- 
tent with the notion that each laminin-like molecule contains 
a heavy chain (A or M). Third, laminin B2 is present in all 
of the BLs studied, suggesting that it is a common subunit 
of all laminin oligomers. Thus, it is possible that structural 
considerations favor the assembly of laminin monomers into 
heterotrimers of A-like, Bl-like, and B2-1ike subunits, with 
diversity arising from the shuffling of homologues in a com- 
mon structure. 
New  data  may  require  revision  of this  scheme.  Other 
laminin-like subunits may exist (e.g., in capillaries or peri- 
neurium) and, as noted above, some laminins may lack a large 
(A-like) subunit. In addition, our immunohistochemical re- 
suits only show coexistence of subunits in a BL, not in an 
individual molecule.  Better evidence on subunit assembly 
can be obtained by analyzing complexes immunoprecipitated 
by the subunit-specific antibodies described herein.  Initial 
results of such experiments are described elsewhere (Engvall 
et al.,  1990). 
The differential distribution of the collagen IV chains also 
suggests combinations in which they may occur. The cd(IV) 
and c~2(IV) chains are known to occur together in a triple 
helical molecule ([cd(IV)]2[c~2(IV)]t),  and their genes share 
a common regulatory element (Timpl,  1989). Our results, 
showing a widespread codistribution of cd(IV) and u2(IV), 
are consistent with their presence in the same molecule. The 
o~3(IV) and a4(IV) chains have not yet been isolated in native 
form, and their mode of association has therefore been in- 
ferred only from the structure of multimers of their COOH- 
terminal globular (NC1) domains (Hudson et al., 1989). Our 
results are those expected if the c¢3(IV) and ct4(IV) chains 
occur together within a  single triple helical molecule. 
The Synaptic Cleft of the Neuromuscular Junction 
Our interest in regional specialization of  BLs stems from evi- 
dence that the BL in the synaptic cleft of the neuromuscular 
junction plays important roles in the formation and main- 
tenance of that synapse. These include specifying the precise 
reinnervation of original synaptic sites during regeneration 
(Sanes et al., 1978), triggering the differentiation of regener- 
ating  axons  into  nerve  terminals  (Glicksman  and  Sanes, 
1983), mediating the adhesion of nerve to muscle (Sanes et 
al.,  1978),  and organizing the differentiation of the post- 
synaptic membrane (Burden et al., 1979). Several molecules 
have been identified that are concentrated in synaptic BL, in- 
cluding a collagen-tailed form of acetylcholinesterase (Mc- 
Mahan et al.,  1978;  Sanes and Hall,  1979; Massoulie and 
Bon,  1982), a heparan sulfate proteoglycan (Anderson and 
Fambrough, 1983), agrin (McMahan and Wallace, 1989), an 
N-acetylgalactosamine-terminated glycoconjugate (Scott et 
al.,  1988), and s-laminin (Hunter et al.,  1989a). Agrin has 
been implicated in the induction of postsynaptic structures 
(McMahan and Wallace, 1989), and s-laminin bears a moto- 
neuron-selective adhesive site (Hunter et al.,  1989b). How- 
ever, the molecular basis of synaptic organization remains 
poorly understood. 
In this context, it is intriguing that the present study has 
provided  evidence  for  three  novel  synapse-concentrated 
polypeptides in BL (laminin A and collagen chains o~3(IV) 
and et4(IV)), for one polypeptide that is excluded from syn- 
aptic  BL (laminin B1),  and  for two polypeptides that are 
depleted from synaptic BL (the cd(IV) and ot2(IV) chains). 
All of  these proteins will now need to be considered as candi- 
date mediators of the functional differences between synaptic 
and extrasynaptic BL. Some specific suggestions along these 
lines are considered below. More generally, the notion that 
synaptic and extrasynaptic BL differ in fundamental ways en- 
courages the  view that  the  structure  of synaptic BL as  a 
whole may be responsible for its functional properties. 
Neuronal Interactions with Laminin and Collagen 
The laminin A, B1, B2 trimer is adhesive to neurons of many 
types,  and  is  a  potent  promoter  of  neurite  outgrowth 
(reviewed in Sanes,  1989).  A  defined site on s-laminin is 
selectively adhesive for motoneurons, and inhibits neurite 
outgrowth on laminin  (Hunter et al.,  1989b;  and unpub- 
lished data).  Merosin is adhesive for at least some neurons 
(Engvall, E., and M. Manthorpe, unpublished data). Thus, 
although  studies  of native  molecules  remain  to  be  com- 
pleted,  it seems likely that the isoforms of laminin are all 
neuroactive but differ in their specificity and effects. 
Individual subunits bear several potential active sites that 
may mediate some of these effects. These include: a potential 
integrin-binding  site,  RGD,  in  laminin  A  (Sasaki  et  al., 
1988); a motoneuron-selective adhesion site, LRE, in s-lam- 
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s-laminin, two in B2, and one in A, but none in B1 (Hunter et 
al.,  1989b); neurite outgrowth-promoting sites in A (Tashiro 
et al., 1989) and B2 (Liesi et al., 1989); and at least two dis- 
crete sites in B1 that bind nonneural cells (Graf et al., 1987; 
Charonis et al.,  1988).  The variations among BLs that we 
have documented here imply that the BLs in peripheral nerve 
and muscle contain different combinations of these sites. For 
example, synaptic sites would bear a high density of LRE's 
in s-laminin and laminin A, whereas endoneurial and extra- 
synaptic BL substitute LRE-less B1 for s-laminin and mero- 
sin M for A. Similarly, the cell-binding sites in laminin B1 
are present in endoneurial and extrasynaptic BLs but absent 
from the synapse. Thus, the variable arrangements of lami- 
nin isoforms in the BLs that regenerating axons encounter 
may serve to display different combinations of active sites to 
axons at different points along their path, thus influencing 
axonal growth and differentiation in complex ways. 
Similar considerations  may apply  to  the  collagens IV. 
Conventional collagen IV (the [al(IV)]2  [c~2(IV)] trimer) is 
adhesive for and promotes  neurite outgrowth from some 
types of neurons (Sanes,  1989).  Collagens have also been 
suggested to influence clustering of acetylcholine receptors 
in muscle membranes (Sanes, 1989). It is tempting to specu- 
late that the o~3(IV) and ~4(IV) chains have unique and/or 
cell  type-specific activities that could influence nerve  or 
muscle at synaptic sites.  Direct tests of this notion await iso- 
lation and characterization of the molecule(s) containing the 
c~3(IV) and tx4(IV) chains. 
Goodpasture Syndrome and Alport Nephritis 
Patients with Goodpasture syndrome, an autoimmune glo- 
merulonephritis,  produce  antibodies that selectively stain 
glomerular BL in normal human kidneys. The c~3(IV) chain 
of collagen IV was discovered as the major target of autoanti- 
bodies in such patients, and has therefore been identified as 
the "Goodpasture antigen" (Butkowski et al.,  1985, 1987; 
Saus et al., 1988; reviewed in Hudson et al., 1989).  Subse- 
quently, ct3(IV) has been implicated in the etiology of Alport 
nephritis, an X-linked disease often accompanied by deaf- 
ness: c~3(IV) is undetectable in patients with Alport's, and 
several results suggest that the Alport locus is linked to the 
structural genes for u3(IV), for ct4(IV), or for the newly dis- 
covered c~5(IV) chain (Kleppel et al., 1987; Hostikka et al., 
1990; reviewed in Hudson et al., 1989; but see Kastan et al., 
1989;  Kleppel et al.,  1989b). 
In light of these intriguing pathological observations, it 
will be of obvious interest to study the neuromuscular junc- 
tions of patients with Goodpasture and Alport nephritis. Al- 
though no major neuromuscular symptoms have been de- 
tected  in  such  individuals,  subtle  abnormalities have  not 
been sought. If  the Alport mutation deletes a specific compo- 
nent of synaptic BL, one could then ask what other compo- 
nents are disordered and what developmental and structural 
abnormalities, if any, result. The obvious difficulty of per- 
forming such analyses with human material may be miti- 
gated by the recent characterization of a  canine model of 
X-linked Alport syndrome in which, as in humans, t~3(IV) 
is apparently lacking and fatal nephritis results (Thorner et 
al.,  1987, 1989). 
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